Mirum Pharma to buy Bluejay Therapeutics for up to $820 million

Group 1 - Mirum Pharmaceuticals will acquire Bluejay Therapeutics in a deal valued at up to $820 million [1] - The acquisition will enhance Mirum's portfolio with a late-stage experimental drug targeting a severe liver disease [1]